| Different ways to die: cell death pathways and their association with spinal cord injury L Guha, N Singh, H Kumar Neurospine 20 (2), 430, 2023 | 19 | 2023 |
| Drug repurposing for spinal cord injury: progress towards therapeutic intervention for primary factors and secondary complications L Guha, H Kumar Pharmaceutical Medicine 37 (6), 463-490, 2023 | 10 | 2023 |
| Gut microbiota and traumatic central nervous system injuries: insights into pathophysiology and therapeutic approaches L Guha, TG Agnihotri, A Jain, H Kumar Life Sciences 334, 122193, 2023 | 7 | 2023 |
| From hope to healing: Exploring the therapeutic potential of exosomes in spinal cord injury N Singh, L Guha, H Kumar Extracellular Vesicle 3, 100044, 2024 | 5 | 2024 |
| Nanotechnological Approaches for the Treatment of Triple-Negative Breast Cancer: A Comprehensive Review L Guha, IA Bhat, A Bashir, JU Rahman, FH Pottoo Current Drug Metabolism 23 (10), 781-799, 2022 | 4 | 2022 |
| Seeing the unseen: The role of bioimaging techniques for the diagnostic interventions in intervertebral disc degeneration G Tripathi, L Guha, H Kumar Bone reports, 101784, 2024 | 2 | 2024 |
| Nanotechnological Advancements For The Theranostic Intervention In Anaplastic Thyroid Cancer: Current Perspectives And Future Direction SS Uppalapati, L Guha, H Kumar, A Mandoli Current Cancer Drug Targets 24 (3), 245-270, 2024 | 2 | 2024 |
| Evaluating the Role of Lin-11, Isl-1, and Mec-3 Kinases in Dopaminergic Neurodegeneration in a Subacute 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson’s Disease Kritika Bhardwaj,Abhishek Roy,Lahanya Guha, Hemant Kumar ACS Pharmacology & Translational Science, 2024 | 1 | 2024 |
| Challenges in Drug Development for Neurological Disorders L Guha, N Singh, H Kumar Drug Delivery Strategies in Neurological Disorders: Challenges and …, 2024 | 1 | 2024 |
Hemant KumarNIPER, Ahmedabad, INDIAכתובת אימייל מאומתת בדומיין niperahm.ac.in
